A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate-1 risk myelodysplastic syndrome (Q50526914)
Jump to navigation
Jump to search
scientific article published in September 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate-1 risk myelodysplastic syndrome |
scientific article published in September 2011 |
Statements
A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate-1 risk myelodysplastic syndrome (English)
1 reference
Stefan Faderl
1 reference
Azra Raza
1 reference
Naomi Galili
1 reference
Scott E Smith
1 reference
John Godwin
1 reference
Ralph V Boccia
1 reference
Han Myint
1 reference
Daruka Mahadevan
1 reference
Deborah Mulford
1 reference
Mark Rarick
1 reference
Gail L Brown
1 reference
Dale Schaar
1 reference
Rami S Komrokji
1 reference
Alan F List
1 reference
Mikkael Sekeres
1 reference
1 September 2011
1 reference
1 reference
118
1 reference
8
1 reference
2138-2147
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference